SHAKEOLOGY Tropical Strawberry Vegan
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
Se questo prodotto fosse venduto in Francia
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte | Massimo giornaliero, adulto |
|---|---|---|
| Grifola frondosa Fonte : Cultured mycelia | 150 mg | Non calcolata |
| Protéine de pois Fonte : Pisum sativum - Graine Potenza : 78 % Protein | 14.200 mg | Non calcolata |
| Salvia hispanica Fonte : Graine(s) | 1.900 mg | Non calcolata |
| Linum usitatissimum Fonte : Graine(s) | 200 mg | Non calcolata |
| Chenopodium quinoa Fonte : Graine(s) | 300 mg | Non calcolata |
| Pisum sativum Fonte : Fibre de graine | 100 mg | Non calcolata |
| Smallanthus sonchifolius Fonte : Racine | 400 mg | Non calcolata |
| Cordyceps militaris Fonte : Cultured mycelia | 200 mg | Non calcolata |
| Chlorella vulgaris Fonte : Cellule brisée | 600 mg | Non calcolata |
| Inuline Fonte : Cichorium intybus - racine | 250 mg | Non calcolata |
| Astragalus membranaceus Fonte : Racine | 250 mg | Non calcolata |
| Myrciaria dubia Fonte : Fruit | 250 mg | Non calcolata |
| Ganoderma lucidum Fonte : Cultured mycelia | 150 mg | Non calcolata |
| Cynorrhodon Fonte : Rosa canina, Fruit | 350 mg | Non calcolata |
| Lepidium meyenii Fonte : Racine | 55 mg | Non calcolata |
| Sulfone de diméthyl Fonte : Sulfone de diméthyl | 150 mg | Non calcolata |
| Withania somnifera Fonte : Racine | 150 mg | Non calcolata |
| Schisandra chinensis Fonte : Fruit | 100 mg | Non calcolata |
| Moringa oleifera Fonte : Feuille | 200 mg | Non calcolata |
| Plukenetia volubilis Fonte : Graine(s) | 50 mg | Non calcolata |
| Bacillus coagulans Fonte : MTCC 5856 | 250 Millions d'UFC | Non calcolata |
| Bacillus coagulans Fonte : Cellule entière | 250 Millions d'UFC | Non calcolata |
| 4-alpha-D-glucane glucanohydrolase Fonte : Alpha-amylase | 200 Unités d'alpha-amylase dextrinifiante du FCC | Non calcolata |
| 4-alpha-D-glucane glucanohydrolase Fonte : Aspergillus flavus var. oryzae - En entier | 200 Unités d'alpha-amylase dextrinifiante du FCC | Non calcolata |
| 4-alpha-D-glucane glucanohydrolase Fonte : Alpha-amylase | 5 mg | Non calcolata |
| 4-alpha-D-glucane glucanohydrolase Fonte : Aspergillus flavus var. oryzae - En entier | 5 mg | Non calcolata |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Fonte : Aspergillus niger - En entier | 300 FCC CU | Non calcolata |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Fonte : Cellulase | 300 FCC CU | Non calcolata |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Fonte : Aspergillus niger - En entier | 4 mg | Non calcolata |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Fonte : Cellulase | 4 mg | Non calcolata |
| bêta-galactosidase Fonte : Lactase | 4 mg | Non calcolata |
| bêta-galactosidase Fonte : Aspergillus flavus var. oryzae - En entier | 4 mg | Non calcolata |
| bêta-galactosidase Fonte : Lactase | 400 FCC ALU | Non calcolata |
| bêta-galactosidase Fonte : Aspergillus flavus var. oryzae - En entier | 400 FCC ALU | Non calcolata |
| 1,4-alpha-D-Glucane glucohydrolase Fonte : Aspergillus niger - En entier | 3 mg | Non calcolata |
| 1,4-alpha-D-Glucane glucohydrolase Fonte : Glucan 1,4-alpha-glucosidase | 3 mg | Non calcolata |
| 1,4-alpha-D-Glucane glucohydrolase Fonte : Aspergillus niger - En entier | 3 Unité de glucoamylase du FCC | Non calcolata |
| 1,4-alpha-D-Glucane glucohydrolase Fonte : Glucan 1,4-alpha-glucosidase | 3 Unité de glucoamylase du FCC | Non calcolata |
| alpha-D-Galactoside galactohydrolase Fonte : alpha-Galactosidase | 15 Unités d'alpha-galactosidase du FCC | Non calcolata |
| alpha-D-Galactoside galactohydrolase Fonte : Aspergillus niger - En entier | 15 Unités d'alpha-galactosidase du FCC | Non calcolata |
| alpha-D-Galactoside galactohydrolase Fonte : alpha-Galactosidase | 1 mg | Non calcolata |
| alpha-D-Galactoside galactohydrolase Fonte : Aspergillus niger - En entier | 1 mg | Non calcolata |
| bêta-fructofuranosidase Fonte : Invertase | 50 FCC SU | Non calcolata |
| bêta-fructofuranosidase Fonte : Saccharomyces cerevisiae - en entier | 50 FCC SU | Non calcolata |
| bêta-fructofuranosidase Fonte : Invertase | 0,5 mg | Non calcolata |
| bêta-fructofuranosidase Fonte : Saccharomyces cerevisiae - en entier | 0,5 mg | Non calcolata |
| Inonotus obliquus Fonte : Cultured mycelia | 150 mg | Non calcolata |
| Malpighia glabra Fonte : Fruit | 70 mg | Non calcolata |
| Avena sativa Fonte : Graine(s) Potenza : 44 % Protein | 5.000 mg | Non calcolata |
| Protéine de riz Fonte : Oryza sativa - Graine Potenza : 79 % Protein | 1.000 mg | Non calcolata |
| Protéine de riz Fonte : Protéine de riz Potenza : 79 % Protein | 1.000 mg | Non calcolata |
Ingredienti non medicinali
Extrait de thé vert, Saveur de fraise, Maltodextrine, Glycosides de stéviol, Chlorure de sodium, Acide citrique, Extrait de fruit de Siraitia Grosvenorii, Feuilles de Camellia Sinensis, Lécithine, Jus de canne à sucre évaporé, Mélange de fruit et légume, Cannellier Casse, Gomme de xanthane
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | Non précisée | 1 Portion(s) | 1 jour |
Usi autorizzati in Canada
Source of antioxidants. Source of/Provides antioxidants that help protect the body from harmful free radicals that can cause cell damage. Workout Supplement. Athletic support. Source of protein for the maintenance of good health. Source of protein which helps build and repair body tissues. Source of amino acids involved in muscle protein synthesis. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet. Digestive enzymes.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Contra-Indications : Do not use if you have any chronic health conditions or are taking other medications without consulting with a health care practitioner. Do not use if you are pregnant or breastfeeding, are allergic to plants of the Asteraceae/Compositae/Daisy family, or are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, diabetes, or an auto-immune disorder consult a health care practitioner prior to use.
Testo originale in inglese.
Cautions and Warnings : Discontinue use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhoea, nausea, vomiting) occur, worsen, or persist beyond 3 days.
Testo originale in inglese.
Known Adverse Reactions : Hypersensitivity/allergy, headaches, heartburn, and bloating have been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal bloating, constipation or indigestion.
Testo originale in inglese.
Scheda del prodotto
- Titolare
- Team Beachbody Canada LP
- NPN o DIN-HM
- 80077867
- Stato
- Licenza attiva
- Data della licenza
- 29 maggio 2017
- Data di revisione
- 2 febbraio 2023
- Forma
- Poudre
- Via di somministrazione
- Orale
- Tipo di domanda
- Non traditionnelle
Fonte
Scheda ufficiale Health Canada, licenza 80077867
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- Linum usitatissimum
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
FLAXSEED - LINUM USITATISSIMUM
Via di somministrazione: Oral
Precauzioni e avvertenze
Si applica ai prodotti: providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
Fonti citate da Health Canada (1)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Condizione di applicazione: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
Fonti citate da Health Canada (2)
- Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
- Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.
Controindicazioni
Si applica ai prodotti: providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
Fonti citate da Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
- Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.
Reazioni avverse note
Condizione di applicazione: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.
- Chlorella vulgaris
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
CHLORELLA - CHLORELLA VULGARIS
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Si applica ai prodotti: providing 250 mg or more of chlorella per day or 6 µg or more vitamin K per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Ohkawa et al. 1995; NNHPD Multi-vitamin/mineral supplements monograph).
Fonti citate da Health Canada (1)
- Ohkawa S, Yoneda Y, Ohsumi Y, Tabuchi M. Warfarin therapy and chlorella. Rinsho Shinkeigaku 1995;35(7):806-807. PubMed Caso clinico
Si applica ai prodotti: containing chlorella enriched with selenium and providing more than 70 µg of selenium per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of non-melanoma skin cancer (Doucha et al. 2009; NNHPD Multi-vitamin/mineral supplements monograph).
Fonti citate da Health Canada (1)
- Doucha J, Livansky K, Kotrbacek V, Zachleder V. Production of Chlorella biomass enriched by selenium and its use in animal nutrition: a review. Applied Microbiology and Biotechnology 2009;83(6):1001-1008. PubMed Articolo di revisione
Reazioni avverse note
Stop use if hypersensitivity/allergy occurs (Tiberg et al. 1995).
Fonti citate da Health Canada (1)
- Tiberg E, Dreborg S, Bjorksten B. Allergy to green algae (Chlorella) among children. Journal of Allergy and Clinical Immunology 1995;96(2):257-259. PubMed
- Astragalus membranaceus
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
Fonti citate da Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.
Controindicazioni
Condizione di applicazione: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
Fonti citate da Health Canada (2)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
- Lepidium meyenii
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
Maca - Lepidium Meyenii
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Si applica ai prodotti: providing 0.6 g or more dried root/hypocotyl, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).
Fonti citate da Health Canada (1)
- Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Studio randomizzato
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Fonti citate da Health Canada (2)
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Studio randomizzato
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
Condizione di applicazione: Healthy mood balance; Sexual health.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Fonti citate da Health Canada (3)
- Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Articolo di revisione
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Studio randomizzato
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
- Withania somnifera
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
ASHWAGANDHA - WITHANIA SOMNIFERA
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Fonti citate da Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Fonti citate da Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.